Furthermore, observations from a study by Krausz et al. indicated that Tregs from tumor-positive lymph nodes from advanced breast cancer patients express increased levels of GITR, compared to tumor-negative lymph nodes (48). Here, TNFRSF18 is linked to neoplasm.